This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
5 Reasons to Add Avis Budget Group (CAR) Stock in Your Portfolio
by Zacks Equity Research
Avis Budget (CAR) remains focused on structurally improving its business amid the pandemic through cost discipline and operational efficiencies.
Reasons to Bet on Cross Country Healthcare (CCRN) Stock
by Zacks Equity Research
Cross Country Healthcare (CCRN) is currently benefiting from the pandemic-induced increase in demand for healthcare staffing, investments in headcount and technology.
Here's Why You Should Retain WEX Stock in Your Portfolio
by Zacks Equity Research
WEX is benefiting from favorable customer spending patterns that continue to rebound from the pandemic blues.
5 Reasons Why You Should Invest in Gartner (IT) Stock Now
by Zacks Equity Research
Gartner (IT) is well poised to gain from its large and diverse addressable market with low customer concentration that helps mitigate operating risks.
Here's Why Investors Should Retain Maximus (MMS) Stock Now
by Zacks Equity Research
Strategic acquisitions and investor-friendly measures boost Maximus (MMS) stock. However, high debt is a headwind.
Is Cross Country Healthcare (CCRN) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how Cross Country Healthcare (CCRN) and CRA International (CRAI) have performed compared to their sector so far this year.
4 Business Services Stocks That More Than Doubled in 2021
by Zacks Equity Research
Driven by the sector's rebound on the back of manufacturing and service strength, a few business services stocks have performed well year to date. Notable among them are CAR, CCRN, HSON and IT.
Reasons to Hold on to ABM Industries (ABM) Stock For Now
by Zacks Equity Research
ABM's multi-year comprehensive strategic plan, ELEVATE, is expected to significantly accelerate the company's organic growth and reinforce profitability.
Accenture (ACN) and BBVA Sign 10-Year Collaborative Agreement
by Zacks Equity Research
Accenture (ACN) lets BBVA use its AI powered SynOps platform for data-driven decision-making, improved operational costs and streamlined services.
Reasons to Retain FLEETCOR Technologies (FLT) in Your Portfolio
by Zacks Equity Research
FLEETCOR's (FLT) top line continues to grow organically, driven by continued strong sales, robust retention levels and same-store sales recovery.
Why Should Investors Bet on CRA International (CRAI) Stock?
by Zacks Equity Research
Solid balance sheet, shareholder-friendly measures and strong international presence boost CRA International (CRAI) shares.
WEX Hires New Talents to Its Global Executive Leadership Team
by Zacks Equity Research
WEX (WEX) welcomes Karen Stroup and Carlos Carriedo to the positions of chief digital officer and chief operating officer, International, respectively.
FTI Consulting (FCN) Appoints New Senior Managing Director
by Zacks Equity Research
FTI Consulting (FCN) welcomes Avigyan Das to the position of senior managing director in its Technology segment in India.
Here's Why You Should Retain IQVIA Holdings (IQV) Stock For Now
by Zacks Equity Research
IQVIA's (IQV) growing client base is a result of the company's ability to standardize, organize and integrate its enormous treasure trove of data.
Here's Why You Should Retain Envestnet (ENV) in Your Portfolio
by Zacks Equity Research
Envestnet's (ENV) technology-enabled services and subscription-based recurring revenue generation capacity is boosting its performance. High debt is a concern.
Can Cross Country Healthcare (CCRN) Stock Continue to Grow Earnings?
by Zacks Equity Research
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Cross Country Healthcare (CCRN).
6 Reasons Investors Should Bet on FTI Consulting (FCN) Stock
by Zacks Equity Research
FTI Consulting's (FCN) international operations help expand its geographic footprint and contribute to top-line growth.
Paychex (PAYX) Set to Report Q2 Earnings: What to Expect?
by Zacks Equity Research
Paychex's (PAYX) second-quarter fiscal 2022 earnings and revenues are likely to have increased year over year.
Here's Why You Should Retain Equifax (EFX) in Your Portfolio
by Zacks Equity Research
Equifax's (EFX) top line has been showing a decent growth rate over the past few years. However, a debt-laden balance sheet remains a concern.
Here's Why You Should Retain Paychex (PAYX) Stock For Now
by Zacks Equity Research
Paychex's (PAYX) solid business model, diversified products and services, and strategic acquisitions boost top-line growth.
Here's Why Investors Should Hold on to Verisk (VRSK) Stock
by Zacks Equity Research
Verisk's (VRSK) growth strategy focuses on organic growth, product development and acquisitions.
ABM Industries (ABM) Gains From Acquisitions Amid High Costs
by Zacks Equity Research
ABM Industries' (ABM) bottom line continues to benefit from greater customer demand for higher-margin COVID-related work orders, efficient management of direct labor and a favorable business mix.
Why Cross Country Healthcare (CCRN) Stock Might be a Great Pick
by Zacks Equity Research
Cross Country Healthcare (CCRN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Here's Why Investors Should Retain Fiserv (FISV) Stock Now
by Zacks Equity Research
The recent acquisition of BentoBox enables Fiserv (FISV) to cater to the increasing demand for capabilities that enhance interaction between merchants and customers online.
Reasons to Retain Green Dot (GDOT) Stock in Your Portfolio
by Zacks Equity Research
Green Dot (GDOT) is expanding its addressable market with the help of its banking-as-a-service (BaaS) account programs.